Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:11:50.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:29:25.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label was updated from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:28:18.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, indicating restricted access. The visible content is replaced by an error page, with typical study details no longer shown.
    Difference
    30%
    Check dated 2026-09-22T23:04:20.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.6 to v3.7.0, indicating a new version of the page content. It signals an update to the page rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-15T20:25:24.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6, indicating a newer version of the study record. This is a metadata update that signals a revision of the page rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-09-01T18:13:58.000Z thumbnail image

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.